Neonatal Screening for Metabolic and Endocrine Disorders
- 10 January 2011
- journal article
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 108, 11-22
- https://doi.org/10.3238/arztebl.2011.0011
Abstract
Neonatal screening for treatable endocrinopathies and inborn errors of metabolism is an important preventive measure. Advances in the diagnosis and treatment of these diseases have made it necessary to expand the screening program. This article is based on a selective literature review and our clinical experience. In 2005, neonatal screening in Germany was expanded from 3 to 14 diseases, as mandated by the responsible governmental authority (the Gemeinsamer Bundesausschuss, i.e., Joint Federal Committee). From 2005 to 2008, screening revealed diseases requiring treatment in 1932 out of a total of 2,758,633 newborns (prevalence, 1 in 1428). The expansion of the screening program resulted in a 57% increase in the overall number of cases detected and a 92% increase for metabolic diseases alone. The German neonatal screening program for treatable endocrinopathies and inborn errors of metabolism is a complex and integrated preventive measure that has become markedly more effective as a result of its expansion in 2005.Keywords
This publication has 15 references indexed in Scilit:
- Revisting wilson and Jungner in the genomic age: a review of screening criteria over the past 40 yearsBulletin of the World Health Organization, 2008
- Combining Immunoreactive Trypsinogen and Pancreatitis-Associated Protein Assays, a Method of Newborn Screening for Cystic Fibrosis that Avoids DNA AnalysisThe Journal of Pediatrics, 2005
- Branched-chain organic aciduriasSeminars in Neonatology, 2002
- Erweiterung des Neugeborenenscreenings durch TandemmassenspektrometrieMonatsschrift Kinderheilkunde, 2001
- Ergebnisse des Neugeborenenscreenings zur Früherkennung des Adrenogenitalen Syndroms in Berlin (1992-1999)Monatsschrift Kinderheilkunde, 2000
- Modellprojekt zur Neuordnung des Neugeborenen-Screenings in Bayern: Konzeption und erste ErgebnisseDas Gesundheitswesen, 2000
- Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millenniumActa Paediatrica, 1999
- Guidelines for neonatal screening programmes for congenital hypothyroidismEuropean Journal of Pediatrics, 1993
- Neugeborenen-Hypothyreose-Screening in der Bundesrepublik Deutschland*: Ergebnisse einer nationalen Umfrage**Deutsche Medizinische Wochenschrift (1946), 1981
- Preliminary CommunicationThe Lancet, 1953